Dr. Reddy's Labs Files 6-K
Ticker: RDY · Form: 6-K · Filed: Dec 31, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, administrative
TL;DR
DRL filed a 6-K, confirming 20-F filing status. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 31, 2025, reporting its status as a foreign private issuer. The company, headquartered in Hyderabad, India, indicated it files annual reports under Form 20-F.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' reporting status as a foreign private issuer, which impacts its disclosure requirements with the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming the company's reporting status and does not contain new financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Filer of the 6-K report
- 0001575872-25-000775 (accession_number) — Unique identifier for the filing
- 20251231 (date) — Filing date and period of report
- Hyderabad, India (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information that the registrant has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange on which its securities are traded.
What does it mean that Dr. Reddy's Laboratories Ltd. files under Form 20-F?
Filing under Form 20-F indicates that Dr. Reddy's Laboratories Ltd. is a foreign private issuer and files its annual reports with the SEC on this form, which has different disclosure requirements than domestic US companies.
When was this Form 6-K filed?
This Form 6-K was filed as of December 31, 2025.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
Dr. Reddy's Laboratories Ltd. is headquartered at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does this filing indicate any new financial results or operational changes?
No, this filing is a routine report of foreign private issuer status and does not appear to contain new financial results or operational changes.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-12-31 11:15:46
Filing Documents
- rdy0835_6k.htm (6-K) — 48KB
- rdy0835_ex99-1.htm (EX-99.1) — 21KB
- rdy0835_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0835_ex99-1img02.jpg (GRAPHIC) — 10KB
- 0001575872-25-000775.txt ( ) — 98KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: December 31, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3